The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0

被引:0
作者
Yujun Cui
Xinzhi Liu
Shuai Li
Hongzhi Wang
Yirong Xiang
Yangzi Zhang
Maxiaowei Song
Jianhao Geng
Zhiyan Liu
Huajing Teng
Xianggao Zhu
Yong Cai
Yongheng Li
Weihu Wang
机构
[1] Peking University Cancer Hospital and Institute,Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
[2] Peking University Cancer Hospital and Institute,Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
来源
Clinical and Translational Oncology | 2024年 / 26卷
关键词
Locally advanced rectal cancer; Neoadjuvant chemoradiotherapy; Tumor regression grade; ypT1-4N0;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1012 / 1021
页数:9
相关论文
共 193 条
[1]  
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]  
Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-164
[3]  
Siegel RL(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933
[4]  
Laversanne M(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625
[5]  
Soerjomataram I(2021)Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 19 329-359
[6]  
Jemal A(2020)Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 31 1291-1305
[7]  
Siegel RL(2010)Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 835-844
[8]  
Miller KD(2020)Outcome measures in multimodal rectal cancer trials Lancet Oncol 21 e252-e264
[9]  
Goding Sauer A(2012)Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy World J Surg 36 675-683
[10]  
Fedewa SA(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776